In ovarian cancer, elevated expression of the ‘oncogenic gene set’ comprising IGF2BP1, SRF, FOXK1 and PDLIM7 was not significantly (P = 0.077) associated with poor overall survival (OS) but showed the expected trend with a HR of 1.22 (Supplementary Figure S7A). This evidence concerns the gene IGF2BP1 and ovarian carcinoma.